Furthermore, the levels of TNF-α, IL-1β, IL-6, and IL-8 in BALF and lung tissues were higher in the ARDS group than in the Sham, and the TAG pretreatment decreased their levels (TAG + ARDS vs. ARDS, 62.82 ± 3.53 vs. 74.69 ± 3.89, 56.53 ± 6.89 vs. 77.55 ± 6.63, 38.34 ± 2.56 vs. 45.68 ± 3.11, and 65.83 ± 3.05 vs. 77.56 ± 3.22 for the BALF, respectively, p < 0.05; TAG + ARDS vs. ARDS, 44.62 ± 4.22 vs. 65.76 ± 3.72, p < 0.01, 51.74 ± 4.52 vs. 67.68 ± 7.19, p < 0.05, 29.36 ± 1.77 vs. 37.94 ± 2.47, p < 0.01, and 53.22 ± 2.87 vs. 65.00 ± 3.47, p < 0.05 for the lung, respectively; Figures 3C, D). The gene discussed is TNF; the disease is acute respiratory distress syndrome.